PortfoliosLab logoPortfoliosLab logo
MEDX vs. QGRD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MEDX vs. QGRD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Horizon Kinetics Medical ETF (MEDX) and Horizon NASDAQ-100 Defined Risk ETF (QGRD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MEDX achieves a 6.55% return, which is significantly lower than QGRD's 10.23% return.


MEDX

1D
1.12%
1M
3.47%
6M
6.78%
YTD
6.55%
1Y
28.56%
3Y*
8.26%
5Y*
10Y*

QGRD

1D
-1.30%
1M
-2.77%
6M
9.01%
YTD
10.23%
1Y
19.20%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDX vs. QGRD - Yearly Performance Comparison


2026 (YTD)2025
MEDX
Horizon Kinetics Medical ETF
6.55%20.72%
QGRD
Horizon NASDAQ-100 Defined Risk ETF
10.23%8.15%

Correlation

The correlation between MEDX and QGRD is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jul 10, 2025

0.07

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDX vs. QGRD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDX
MEDX Risk / Return Rank: 5959
Overall Rank
MEDX Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
MEDX Sortino Ratio Rank: 6565
Sortino Ratio Rank
MEDX Omega Ratio Rank: 5151
Omega Ratio Rank
MEDX Calmar Ratio Rank: 6969
Calmar Ratio Rank
MEDX Martin Ratio Rank: 5353
Martin Ratio Rank

QGRD
QGRD Risk / Return Rank: 4545
Overall Rank
QGRD Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
QGRD Sortino Ratio Rank: 4242
Sortino Ratio Rank
QGRD Omega Ratio Rank: 4343
Omega Ratio Rank
QGRD Calmar Ratio Rank: 5050
Calmar Ratio Rank
QGRD Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDX vs. QGRD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Horizon Kinetics Medical ETF (MEDX) and Horizon NASDAQ-100 Defined Risk ETF (QGRD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDXQGRDDifference
Sharpe ratioReturn per unit of total volatility

+0.21

Sortino ratioReturn per unit of downside risk

+0.62

Omega ratioGain probability vs. loss probability

1.26

1.23

+0.03

Calmar ratioReturn relative to maximum drawdown

2.72

2.05

+0.67

Martin ratioReturn relative to average drawdown

7.29

6.18

+1.11

MEDX vs. QGRD - Sharpe Ratio Comparison

The current MEDX Sharpe Ratio is 1.52, which is comparable to the QGRD Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of MEDX and QGRD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MEDX vs. QGRD - Drawdown Comparison

The maximum MEDX drawdown since its inception was -23.10%, which is greater than QGRD's maximum drawdown of -9.41%. Use the drawdown chart below to compare losses from any high point for MEDX and QGRD.


Loading charts...

Drawdown Indicators


MEDXQGRDDifference

Max Drawdown

Largest peak-to-trough decline

-23.10%

-9.41%

-13.69%

Max Drawdown (1Y)

Largest decline over 1 year

-10.54%

-9.41%

-1.13%

Max Drawdown (3Y)

Largest decline over 3 years

-23.10%

Current Drawdown

Current decline from peak

-6.14%

-4.34%

-1.80%

Average Drawdown

Average peak-to-trough decline

-6.58%

-2.25%

-4.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.93%

3.11%

+0.82%

Volatility

MEDX vs. QGRD - Volatility Comparison

Horizon Kinetics Medical ETF (MEDX) has a higher volatility of 7.07% compared to Horizon NASDAQ-100 Defined Risk ETF (QGRD) at 5.86%. This indicates that MEDX's price experiences larger fluctuations and is considered to be riskier than QGRD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDXQGRDDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.07%

5.86%

+1.21%

Volatility (6M)

Calculated over the trailing 6-month period

14.26%

11.69%

+2.57%

Volatility (1Y)

Calculated over the trailing 1-year period

18.98%

14.72%

+4.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.21%

14.61%

+2.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.21%

14.61%

+2.60%

MEDX vs. QGRD - Expense Ratio Comparison

Both MEDX and QGRD have an expense ratio of 0.85%.


Dividends

MEDX vs. QGRD - Dividend Comparison

MEDX's dividend yield for the trailing twelve months is around 1.16%, less than QGRD's 1.42% yield.


PositionTTM202520242023
MEDX
Horizon Kinetics Medical ETF
1.16%1.23%1.92%4.94%
QGRD
Horizon NASDAQ-100 Defined Risk ETF
1.42%1.57%0.00%0.00%

Frequently Asked Questions


MEDX and QGRD have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MEDX has higher volatility (7.07%) compared to QGRD (5.86%). In terms of maximum drawdown, MEDX dropped -23.10% vs QGRD's -9.41%.

On 1-year performance, MEDX leads with 28.56% vs 19.20% for QGRD. Both ETFs have the same 0.85% expense ratio. On volatility, QGRD has been the lower-risk option at 5.86%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, MEDX has performed better with a 28.56% return vs 19.20%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

MEDX and QGRD have the same expense ratio: 0.85% per year.

QGRD has the higher dividend yield at 1.42%, compared with 1.16% for MEDX.

MEDX is categorized as Health & Biotech Equities, while QGRD is Equity Hedged.

MEDX currently has the higher Sharpe Ratio (1.52 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MEDX and QGRD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer